[ad_1]
By Pushkala Aripaka
(Reuters) – No causal link between COVID-19 vaccines and menstrual disorders has been found so far, the European medicines regulator said on Friday, separately recommending that three new conditions be added as possible side effects of the J&J coronavirus vaccine.
The European Medicines Agency said its safety committee had studied cases of menstrual disturbances reported after vaccination, adding that it had requested more data from vaccine developers to assess the problem.
Menstrual disorders can occur for a variety of reasons, ranging from stress and fatigue to underlying medical conditions such as fibroids and endometriosis.
Separately, the EMA recommended on Friday that immune thrombocytopenia, or hypoplasia of blood platelets, dizziness and tinnitus, or ringing in the ears, be added to J & J’s single-shot vaccine labels as effects potential unwanted.
The EU agency stressed that the benefits of J & J’s vaccine always outweighed the risks, adding that it had analyzed 1,183 cases of dizziness and more than 100 cases of tinnitus to reach its conclusion.
“We strongly support raising awareness of the signs and symptoms of rare events to ensure that they can be quickly identified and treated effectively,” US-based J&J said in a statement, adding that the data on adverse reactions are periodically shared with regulators.
Last month, the EMA listed a rare nerve degeneration disorder, Guillain-Barré syndrome (GBS), among the possible rare side effects of J&J injection. The company also has supply difficulties in the European Union.
The EMA also added GBS as a possible side effect of AstraZeneca’s COVID-19 vaccine, and said on Friday it was still monitoring those reports.
The J&J and AstraZeneca vaccines use similar technology but with different versions of a cold virus to provide immunity-boosting instructions to the body.
(Report by Pushkala Aripaka and Yadarisa Shabong in Bengaluru, edited by Shounak Dasgupta and Frances Kerry)
[ad_2]
Source link